Skip to main content
. 2016 Dec 30;8(10):16728–16743. doi: 10.18632/oncotarget.14377

Figure 3. Fli-1 transactivating compounds induce megakaryocytic differentiation in erythroleukemia cell lines.

Figure 3

Treatment of the erythroleukemic cell lines HEL A. and CB7 B. with A236 and TPA increases the percentage and level of CD41 expression, 48 hours post- treatment. C. These compounds only weakly induce CD41 expression in K562 cells. Compound concentration, 5μM.